The DOI matches its Crossref record; 68 of the 86 references it cites were found in a registry or an index.
Insoluble drug delivery strategies: review of recent advances and business prospects
Open accessAbstract
The emerging trends in the combinatorial chemistry and drug design have led to the development of drug candidates with greater lipophilicity, high molecular weight and poor water solubility. Majority of the failures in new drug development have been attributed to poor water solubility of the drug. Issues associated with poor solubility can lead to low bioavailability resulting in suboptimal drug delivery. About 40% of drugs with market approval and nearly 90% of molecules in the discovery pipeline are poorly water-soluble. With the advent of various insoluble drug delivery technologies, the challenge to formulate poorly water soluble drugs could be achieved. Numerous drugs associated with poor solubility and low bioavailabilities have been formulated into successful drug products. Several marketed drugs were reformulated to improve efficacy, safety and patient compliance. In order to gain marketing exclusivity and patent protection for such products, revitalization of poorly soluble drugs using insoluble drug delivery technologies have been successfully adopted by many pharmaceutical companies. This review covers the recent advances in the field of insoluble drug delivery and business prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 90% of preclinical small molecule candidate drugs have poor solubility, so the realization of this process is very challenging.282”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving drug solubility for oral delivery using solid dispersions
Leuner, C. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00076-x · Cited by 2,581
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, Þ., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,179
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,810
Cyclodextrins and their pharmaceutical applications
Loftsson, Þ., & Duchêne, D. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,766
Salt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,443
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,408
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,256
Pharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, Þ., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,088
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Oerlemans, C., Bult, W., Bos, M. A., Storm, G., Nijsen, J. F. W., & Hennink, W. E. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0233-4 · Cited by 969
Flagged first, then by citations
18 of the 86 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Durate, 2011, Overcoming poor bioavailability through amorphous solid dispersions, Ind Pharm, 30, 4
- Miller DA. Improved oral absorption of poorly water-soluble drugs by advanced solid dispersion systems [dissertation]. Austin: University of Texas; 2007
- Kaparissides, 2006, Recent advances in novel drug delivery systems, J Nanotechnol, 2, 1
Cited by
Sorted by citations
Items 501–600 of 1,000
Thermodynamic Stability Is a Poor Indicator of Cocrystallization in Models of Organic Molecules
Pimonova, Y. A., Carpenter, J. E., & Gruenwald, M. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.3c13030 · Cited by 20
Quality-by-design approach for the development of telmisartan potassium tablets
Oh, G.-H., Park, J., Shin, H., Kim, J.-E., & Park, Y.-J. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1414233 · Cited by 20
Owen, L., Webb, J. P., Green, J. D., Smith, L. J., & Laird, K. (2020) · Phytotherapy Research · doi:10.1002/ptr.6631 · Cited by 20
Abou‐Taleb, H. A., Fathalla, Z. M. A., & Abdelkader, H. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105562 · Cited by 20
Mukherjee, I., Ghosh, A., Bhadury, P., & De, P. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00328b · Cited by 20
Vanhecke, D., Bugada, V., Steiner, R., Polić, B., & Buch, T. (2024) · Lab Animal · doi:10.1038/s41684-024-01409-z · Cited by 19
Sathuvan, M., Min, S., Narayanan, K., Gaur, A., Hong, H., Vivek, R., Ganapathy, A., Cheong, K., Kang, H., & Thangam, R. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.157272 · Cited by 19
Prasad, R., Panwar, K., Katla, J., & Dalvi, S. V. (2020) · Crystal Growth & Design · doi:10.1021/acs.cgd.0c00382 · Cited by 19
Chinraj, V., & Sureshkumar, R. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.120701 · Cited by 24
Zhang, G., Guan, H., Li, J., Li, M., Sui, X., Tian, B., Dong, H., Liu, B., He, Z., Li, N., et al. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.09.001 · Cited by 19
Barzegar-Jalali, M., Jafari, P., Hemmati, S., & Jouyban, A. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.121185 · Cited by 19
A Compendium of Bioavailability Enhancement via Niosome Technology
Sharma, S., Kumari, N., Garg, D., & Chauhan, S. (2023) · Pharmaceutical Nanotechnology · doi:10.2174/2211738511666230309104323 · Cited by 19
Recio-Ruiz, J., Carloni, R., Ranganathan, S., Muñoz‐Moreno, L., Carmena, M. J., Ottaviani, M. F., de la Mata, F. J., & García‐Gallego, S. (2023) · Chemistry of Materials · doi:10.1021/acs.chemmater.2c03436 · Cited by 19
Chung, J. Y., Ko, J. H., Lee, Y. J., Choi, H. S., & Kim, Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.028 · Cited by 19
di Cagno, M. P., & Stein, P. C. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.04.005 · Cited by 19
Dong, B., Lim, L. M., & Hadinoto, K. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.105035 · Cited by 19
Soundararajan, R., Wang, G., Petkova, A., Uchegbu, I. F., & Schätzlein, A. G. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00294 · Cited by 20
Halder, S., Ahmed, F., Shuma, M. L., Azad, M. A. K., & Kabir, E. R. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05026 · Cited by 19
Zhang, Z., Patel, S. B., & King, M. R. (2020) · Molecules · doi:10.3390/molecules26010157 · Cited by 20
Covalent and non-covalent albumin binding of Au(i) bis-NHCs via post-synthetic amide modification†
Sen, S., Perrin, M. W., Sedgwick, A. C., Lynch, V., Sessler, J., & Arambula, J. (2021) · Chemical Science · doi:10.1039/d1sc01055g · Cited by 12
An overview on nanoplatforms for statins delivery: Perspectives for safe and effective therapy
Etemad, L., Salmasi, Z., Moosavian Kalat, S. A., Moshiri, M., Zamanian, J., Kesharwani, P., & Sahebkar, A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116572 · Cited by 18
Lavan, M., & Knipp, G. T. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1080-6 · Cited by 18
Liu, W., Li, D., Dong, Z., Liu, K., He, H., Lü, Y., Wu, W., Li, Q., Gan, L., & Qi, J. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119682 · Cited by 18
Phase Behavior of Non‐Ionic Surfactant‐Medium Chain Triglyceride‐Water Microemulsion Systems
Callender, S. P., & Wettig, S. D. (2021) · Journal of Surfactants and Detergents · doi:10.1002/jsde.12510 · Cited by 18
Gowda, B. H. J., Nechipadappu, S. K., Shankar, S. J., Chavali, M. S., Paul, K., Ahmed, M. G., Sanjana, A., & Shanthala, H. K. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.05.535 · Cited by 18
Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities
Wang, P., Wang, Y., Li, P., Chen, C., Ma, S., Zhao, L., He, H., Yin, T., Zhang, Y. X., Tang, X., et al. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.07.034 · Cited by 18
Kamal, M. M., & Nazzal, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.045 · Cited by 18
Córdoba, A. V. D., Aiassa, V., Longhi, M. R., Quevedo, M. A., & Zoppi, A. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01706-z · Cited by 18
Sadat, S. M. A., de Paiva, I. M., Shire, Z., Sanaee, F., Morgan, T. D. R., Paladino, M., Karimi‐Busheri, F., Mani, R. S., Martin, G. R., Jirik, F. R., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.034 · Cited by 18
Usnic Acid: Potential Role in Management of Wound Infections
Francolini, I., Piozzi, A., & Donelli, G. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_260 · Cited by 18
Nanotherapeutics for the Treatment of Cancer and Arthritis
Patel, P., Meghani, N., Kansara, K., & Kumar, A. (2018) · Current Drug Metabolism · doi:10.2174/1389200220666181127102720 · Cited by 19
Shokoya, M. M., Szabó, E., Nagy, Z. K., Sebe, I., & Zelkó, R. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2619643 · Cited by 17
Cell-penetrating peptide-conjugated copper complexes for redox-mediated anticancer therapy
Peña, Q., Rodríguez-Calado, S., Simaan, A. J., Capdevila, M., Bayón, P., Palacios, Ò., Lorenzo, J., & Iranzo, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1060827 · Cited by 18
Yusop, A. H. M., Sarian, M. N., Januddi, F., & Nur, H. (2022) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2022.11.002 · Cited by 16
Myślińska, M., Stocker, M. W., Ferguson, S., & Healy, A. M. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.02.012 · Cited by 17
Luu, C. H., Nguyen, D. T. D., Chee, C. Y., Thi, T. C. N., Nguyen, D. Y. P., Nguyen, D. H., & Nguyen, C. K. (2023) · Journal of Applied Polymer Science · doi:10.1002/app.54108 · Cited by 17
Mohammadi, H. S., Asl, A. H., & Khajenoori, M. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104621 · Cited by 17
Combining machine learning and molecular simulations to predict the stability of amorphous drugs
Barnard, T., & Sosso, G. C. (2023) · The Journal of Chemical Physics · doi:10.1063/5.0156222 · Cited by 17
Lomba, L., Polo, A., Martínez, N., Alejandre, J., & Giner, B. (2024) · ChemistrySelect · doi:10.1002/slct.202305218 · Cited by 17
Ueda, K., Takemoto, S., Higashi, K., & Moribe, K. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.06.017 · Cited by 17
Mu, J., Ding, X., Song, Y., Mi, B., Fang, X., Chen, B., Yao, B., Sun, X., Yuan, X., Guo, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202409562 · Cited by 17
Yang, D. H., Kim, H. J., Kim, J., Chun, H. J., & Park, K. (2016) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2016.09.018 · Cited by 17
Xu, H., Nagasaka, S., Kameta, N., Masuda, M., Ito, T., & Higgins, D. A. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp03672h · Cited by 17
Berben, P., Stappaerts, J., Vink, M. J. A., Domínguez‐Vega, E., Somsen, G. W., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.06.025 · Cited by 17
Schikarski, T., Trzenschiok, H., Avila, M., & Peukert, W. (2019) · Chemical Engineering & Technology · doi:10.1002/ceat.201900095 · Cited by 17
Khandavilli, U. B. R., Yousuf, M., Schaller, B. E., Steendam, R. R. E., Keshavarz, L., McArdle, P., & Frawley, P. J. (2019) · CrystEngComm · doi:10.1039/c9ce01625b · Cited by 17
Locarno, S. A., Argentiere, S., Ruffoni, A., Maggioni, D., Soave, R., Bucci, R., Erba, E., Lenardi, C., Gelmi, M. L., & Clerici, F. (2020) · RSC Advances · doi:10.1039/c9ra10981a · Cited by 17
Wi, T. I., Won, J. E., Lee, C. M., Lee, J., Kang, T. H., Shin, B. C., Han, H. D., & Park, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272319 · Cited by 18
Wimalasiri, V. W., Dunuweera, S. P., Dunuweera, A. N., & Rajapakse, R. M. G. (2021) · BioMed Research International · doi:10.1155/2021/6657482 · Cited by 17
Surface modification of paper-based microfluidic devices via initiated chemical vapor deposition
Bacheller, S., & Gupta, M. (2024) · Lab on a Chip · doi:10.1039/d4lc00414k · Cited by 16
Crystal engineering for poorly water-soluble drugs: From design to applications
Chen, A., Peng, Y., Chen, Z., Lu, Y., Guo, M., & Cai, T. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.003 · Cited by 16
Process Intensification in Continuous Crystallization
Stelzer, T., Lakerveld, R., & Myerson, A. S. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013581-00266 · Cited by 16
Gobbo, D., Ballone, P., Decherchi, S., & Cavalli, A. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00166 · Cited by 16
Physicochemical Study of Albumin Nanoparticles with Chlorambucil
Kulig, K., Ziąbka, M., Pilarczyk, K., Owczarzy, A., Rogóż, W., & Maciążek-Jurczyk, M. (2022) · Processes · doi:10.3390/pr10061170 · Cited by 16
Impact of solvent properties on the precipitation of active pharmaceutical ingredients
Schikarski, T., Trzenschiok, H., Avila, M., & Peukert, W. (2022) · Powder Technology · doi:10.1016/j.powtec.2022.118032 · Cited by 20
Deep Eutectic Solvents: Fundamental Aspect, Characterizations and Applications
Dangre, P. V., Borase, H. P., Gunde, M. C., Pethe, A. M., & Borkar, M. R. (2022) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/2667387817666221228141746 · Cited by 16
Thủy, L. T. T., Lee, S., Dongquoc, V., & Choi, J. S. (2023) · Antioxidants · doi:10.3390/antiox12020437 · Cited by 16
Advances in solvent based cocrystallization: Bridging the gap between theory and practice
Sarangi, S., Remya, P. N., & Damodharan, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105619 · Cited by 16
Czajkowska-Kośnik, A., Misztalewska‐Turkowicz, I., Wilczewska, A. Z., Basa, A., & Winnicka, K. (2024) · Materials · doi:10.3390/ma17163923 · Cited by 16
Ascorbyl palmitate nanofiber-reinforced hydrogels for drug delivery in soft tissues
Shamiya, Y., Chakraborty, A., Zahid, A. A., Bainbridge, N. A., Guan, J., Feng, B., Pjontek, D., Chakrabarti, S., & Paul, A. (2024) · Communications Materials · doi:10.1038/s43246-024-00641-x · Cited by 16
Ebadi, A., Rafati, A. A., Bavafa, S., & Mohammadi, M. (2017) · Applied Surface Science · doi:10.1016/j.apsusc.2017.07.046 · Cited by 16
Layer-by-Layer coated drug-core nanoparticles as versatile delivery platforms
Paiva‐Santos, A. C., Caldas, M., Pattekari, P. P., Ribeiro, C., Ribeiro, A. J., LVOV, Y. M., & Veiga, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00016-8 · Cited by 16
Sadat, S. M. A., Vakili, M. R., de Paiva, I. M., Weinfeld, M., & Lavasanifar, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111033 · Cited by 16
Solomon, S., Iqbal, J., & Albadarin, A. B. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.017 · Cited by 16
Zafar, A., Alruwaili, N. K., Imam, S. S., Alsaidan, O. A., Alharbi, K. S., Mostafa, E. M., Musa, A., Gilani, S. J., Ghoneim, M. M., Alshehri, S., et al. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102932 · Cited by 16
Pulmonary Drug Delivery System: Newer Patents
Kaur, S. S. (2017) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2017-0019 · Cited by 16
Ahmadi, M., Madrakian, T., & Ghavami, S. (2018) · Methods in molecular biology · doi:10.1007/7651_2018_191 · Cited by 16
Insight into the Structure and Properties of Novel Imidazole-Based Salts of Salicylic Acid
Martins, I. C. B., Al‐Sabbagh, D., Meyer, K., Maiwald, M., Scholz, G., & Emmerling, F. (2019) · Molecules · doi:10.3390/molecules24224144 · Cited by 16
Lokole, P. B., Ngombe, N. K., Motomba, D. I., Safari, J. B., Mpuza, M. K., Krause, R. W. M., Mutwale, P. K., & Nkanga, C. I. (2024) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2024.100055 · Cited by 17
Li, Z., Yao, L., Liu, Z., Wang, L., Ruan, H., Shen, Y., Zhang, P., Li, K., Wang, H., Fan, L., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18020183 · Cited by 15
Dry Gels: Concept, Current Trends, and New Avenues in Drug Delivery and Biomedical Application
Boruah, M., & Sarma, A. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500863 · Cited by 18
Role of Salt Selection in Drug Discovery and Development
Acharya, P. C., Marwein, S., Mishra, B., Ghosh, R., Vora, A., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814423-7.00013-7 · Cited by 15
Yadav, M., Sarolia, J., Vyas, B., Lalan, M. S., Mangrulkar, S. V., & Shah, P. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02138-z · Cited by 15
Sarkar, S., Sadhukhan, P., Das, D., Basyach, P., Das, J., Das, M. R., Saikia, L., Wann, S. B., Kalita, J., Sil, P. C., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c05974 · Cited by 15
Yue, H., Wang, J., & Lu, M. (2023) · Crystal Growth & Design · doi:10.1021/acs.cgd.2c01441 · Cited by 15
Das, S., Solra, M., Sahoo, J., Srivastava, A., Fathima, S., De, M., & Rana, S. (2023) · Chemistry of Materials · doi:10.1021/acs.chemmater.3c02173 · Cited by 15
Levet, G., Krykun, S., Cornelio, B., Pilato, S., Moffa, S., Fontana, A., Gouhier, G., & Estour, F. (2024) · Processes · doi:10.3390/pr12030478 · Cited by 15
Zaleski, M. H., Omo‐Lamai, S., Nong, J., Chase, L. S., Myerson, J. W., Glassman, P. M., Lee, F. T., Reyes‐Esteves, S., Wang, Z., Patel, M. N., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.070 · Cited by 18
Development of a novel progesterone analog in the treatment of traumatic brain injury
Sayeed, I., Wali, B., Guthrie, D. B., Saindane, M., Natchus, M. G., Liotta, D. C., & Stein, D. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.013 · Cited by 15
Zhao, Q., Liu, X., Veldhuis, S. C., & Zhitomirsky, I. (2019) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2019.124382 · Cited by 15
In-Silico Screening of Lipid-Based Drug Delivery Systems
Brinkmann, J., Exner, L., Luebbert, C., & Sadowski, G. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-02955-0 · Cited by 15
Clinical translation status of nanoformulations
Shukla, R., Thok, K., Kakade, S., Handa, M., & Beg, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821095-6.00012-4 · Cited by 15
Bērziņš, K., Fraser‐Miller, S. J., Walker, G. F., Rades, T., & Gordon, K. C. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00540 · Cited by 15
Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer’s Disease Treatment
Séguy, L., Guyon, L., Maurel, M., Verdié, P., Davis, A., Corvaisier, S., Lisowski, V., Dallemagne, P., Groo, A., & Malzert‐Fréon, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101626 · Cited by 16
Identification and validation of LGR5-binding peptide for molecular imaging of gastric cancer
Kwak, M. H., Yang, S. M., Yun, S. K., Kim, S., Choi, M., & Park, J. M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.073 · Cited by 15
He, S., Radeke, C., Jacobsen, J. B., Lind, J. U., & Mu, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.121236 · Cited by 15
Vakali, V., Papadourakis, M., Georgiou, N., Zoupanou, N., Diamantis, D. A., Javornik, U., Papakyriakopoulou, P., Plavec, J., Valsami, G. N., Tzakos, A. G., et al. (2022) · Molecules · doi:10.3390/molecules27175490 · Cited by 15
Supercritical Fluids and Nanoparticles in Cancer Therapy
Marco, I. D. (2022) · Micromachines · doi:10.3390/mi13091449 · Cited by 15
Barroso, N., Andreo, J., Beobide, G., Castillo, Ó., Luque, A., Pérez‐Yáñez, S., & Wuttke, S. (2023) · Communications Chemistry · doi:10.1038/s42004-022-00799-w · Cited by 16
Wang, C., Yan, T., Yan, T., & Wang, Z. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.134947 · Cited by 15
Volkova, Т. V., Domanina, E. N., Kumeev, R. S., Proshin, A. N., & Terekhova, I. V. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.08.062 · Cited by 15
Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Hatamipour, M., Jaafari, M. R., Momtazi‐Borojeni, A. A., Ramezani, M., & Sahebkar, A. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190705120011 · Cited by 15
Cerra, S., Matassa, R., Beltrán, A. M., Familiari, G., Battocchio, C., Píš, I., Sciubba, F., Scaramuzzo, F. A., Giudice, A. D., & Fratoddi, I. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111337 · Cited by 15
Shanthala, H. K., Jayaprakash, H. V., Muniganti, R. K., Gowda, B. H. J., Paul, K., Shankar, S. J., Ahmed, M. G., & Sanjana, A. (2021) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2021v13i1.40054 · Cited by 15
Nanoparticles as Drug Delivery Systems
Carissimi, G., Montalbán, M. G., Fuster, M. G., & Víllora, G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100253 · Cited by 15
Nasal Bioadhesive Drug Delivery Systems and Their Applications
Badhe, R. V., & Nipate, S. S. (2020) · Wiley eBooks · doi:10.1002/9781119640240.ch10 · Cited by 16
Crystal Engineering to Design of Solids: From Single to Multicomponent Organic Materials
Araya‐Sibaja, A. M., Fandaruff, C., Wilhelm-Romero, K., Vega‐Baudrit, J. R., Guillén-Girón, T., & Navarro-Hoyos, M. (2019) · Mini-Reviews in Organic Chemistry · doi:10.2174/1570193x16666190430153231 · Cited by 14
Mohandoss, S., Sukanya, R., Ganesan, S., Alkallas, F. H., Trabelsi, A. B. G., Kusmartsev, F. V., Velu, K. S., Thambusamy, S., Lo, H., & Lee, Y. R. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120292 · Cited by 14
Mitrović, J. R., Divović, B., Knutson, D. E., Petković, M., Djorovic, D. J., Randjelovic, D. V., Dobričić, V., Đoković, J. B., Lunter, D. J., Cook, J. M., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122613 · Cited by 14
Arumugam, N., M., D. D. V., Venketesh, V., Pradhan, S. S., Garg, A., Sivaramakrishnan, V., Kanchi, S., & Mahalingam, S. M. (2024) · RSC Advances · doi:10.1039/d4ra02432j · Cited by 14
Metadata
- Authors
- Kalepu, S., & Nekkanti, V.
- Affiliations
- Western University of Health Sciences (US)
- Corresponding author
- Kalepu, Sandeep
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 5
- Issue
- 5
- Pages
- 442-453
- ISSN
- 2211-3835 (ISSN-L)
- PMC
- PMC4629443
- OpenAlex
- W1195955210
- Cited by
- 1,410
- References
- 86
- Citations by year
- 2026: 111 · 2025: 140 · 2024: 148 · 2023: 166 · 2022: 155 · 2021: 179 · 2020: 191 · 2019: 139 · 2018: 95 · 2017: 62 · 2016: 20 · 2015: 2
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Acta Pharmaceutica Sinica B (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- poorly water-soluble drugs, drug solubility, bioavailability, drug formulation, drug reformulation, pharmaceutical patents, marketing exclusivity, lipophilic drugs, high molecular weight drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review